BiDil for Black Heart Failure Patients
September 1, 2006 by Lei
Filed under Diseases & Conditions
Radio and print advertisements will begin next week selling BiDil to black heart failure patients in Detroit, Houston, and Washington. With the heart drug’s controversial background, maker NitroMed is focusing more on quality-of-life than the race of the target patient population.
Although BiDil is approved only for use by the estimated 750,000 U.S. blacks with heart failure, a 60-second radio spot that will kick off the media campaign makes just one direct reference to race, noting that BiDil is “FDA-approved to treat heart failure in African-American patients.”
If a drug were available for the racial group you belong to, would you be interested in taking it? Take the poll in the sidebar to your right!
MSN Money, August 31, 2006
Technorati Tags: bidil, african-american, blacks, personalized medicine, genetics, heart disease, heart failure, heart, disease, illness, health
